Eric Hyllengren | VP of IR and Finance |
Pascal Touchon | President and CEO |
Jakob Dupont | EVP and Global Head of Research and Development |
Utpal Koppikar | CFO |
AJ Joshi | Chief Medical Officer |
Kristin Yarema | Chief Commercial Officer |
Salim Syed | Mizuho |
Matt Phipps | William Blair |
John Newman | Canaccord |
Tessa Romero | JPMorgan |
Phil Nadeau | Cowen |
Jonathan Miller | Evercore |
Yigal Nochomovitz | Citi |
Good day, ladies and gentlemen, and welcome to Atara Biotherapeutics Quarter Three 2021 Financial Results Conference Call. [Operator Instructions] At this time, it is my pleasure to turn the floor over to your host Eric Hyllengren, VP, Investor Relations and Finance. Sir, the floor is yours.
Thank you, operator. Good morning, everyone, and welcome to Atara's third quarter 2021 results conference call.